The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.

Financial leaders are forgoing the biggest climate conference on the calendar, and Spain has a plan to make it easier for companies within the European Union to raise money. Plus, Boeing is dealing ...

Activist investor Starboard Value has taken a stake of about US$1bil in Pfizer Inc and is seeking to spur a turnaround of the ...

Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary.

Bailey will replace incumbent Gary Swidler, who has been in the role for nearly a decade, on March 31. Swidler would, however ...

Ultragenyx Pharmaceutical said Monday that it has received breakthrough therapy designation from the Food and Drug Administration for its treatment to reduce the risk of fracture associated with ...

Starboard Value, an activist investment firm, has taken a significant $1 billion stake in Pfizer, signaling its intent to ...

The company’s covid vaccine and treatment more than doubled its revenue — to $100bn (€89.5bn) in 2022 from $42bn (€37.6bn) in ...

Barcelona, Spain (October 5, 2024) – The start of racing in the Women’s America’s Cup had the six AC40 crew representing the ...

An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories.